Steven Cohen’s BioNTech BNTX Stock Holding History

Steven Cohen’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.4M	Buy	+327,184	New	+$30.8M	0.03%	649
2024 Q4	–	Sell	-361,993	Closed	-$43M	–	2093
2024 Q3	$43M	Sell	361,993 -99,718	-22%	-$9.17M	0.11%	217
2024 Q2	$37.1M	Buy	461,711 +341,311	+283%	+$31.2M	0.1%	276
2024 Q1	$11.1M	Buy	+120,400	New	+$11.5M	0.03%	678
2023 Q1	–	Sell	-302,600	Closed	-$45.5M	–	2245
2022 Q4	$45.5M	Buy	302,600 +192,600	+175%	+$29.6M	0.15%	175
2022 Q3	$14.8M	Buy	+110,000	New	+$16.8M	0.06%	400
2022 Q1	–	Sell	-88,700	Closed	-$22.9M	–	1181
2021 Q4	$22.9M	Buy	+88,700	New	+$24.3M	0.09%	304

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Steven Cohen's BNTX Position: Q2 2026 in Review

Steven Cohen opened a new position in BioNTech (BNTX) in Q2 2026: 327,184 shares worth $30.4M. The stake represents 0.03% of the portfolio and ranks #649 among its holdings. This is a return to the name: Steven Cohen previously reported a position in BNTX as recently as Q3 2024.

Steven Cohen first reported a position in BNTX in Q4 2021 and has held it in 7 quarters since. The position peaked at $45.5M in Q4 2022. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Steven Cohen held 327,184 shares of BioNTech worth $30.4M as of Q2 2026.
BioNTech was a new Steven Cohen position in Q2 2026.
BioNTech made up 0.03% of Steven Cohen's portfolio in Q2 2026, its #649 holding.
Steven Cohen first reported a position in BioNTech in Q4 2021 and has held it in 7 quarters since.
Steven Cohen's BioNTech position peaked at $45.5M in Q4 2022.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.